Home
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

NCT02340780

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

QEII Health Sciences Centre Halifax, Nova Scotia, Canada

View Trial Details

Completed

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

NCT03010358

Conditions: Anemia, B-Cell Prolymphocytic Leukemia, Chronic Disease, +36 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

NCT00443976

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada

Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada

View Trial Details

Completed

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

NCT03702231

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Compare SHINGRIX Vaccine Response Rates, +28 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia

NCT01627054

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: CancerCare Manitoba Winnipeg, Manitoba, Canada

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

NCT00390117

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +40 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell

NCT03019055

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations: Froedtert Hospital & Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies

NCT04748185

Conditions: B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +21 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia

NCT05007860

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT

NCT05928156

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Related conditions